Nonprescription Drug Rules Delayed by Presidential Pause
Published Date: 1/27/2025
Rule
Summary
The new rule about nonprescription drugs with extra conditions won’t start until March 21, 2025, thanks to a presidential pause for review. This affects drug makers and sellers who need to follow new safety steps before selling certain over-the-counter meds. No extra costs or changes happen until the new date, giving everyone more time to get ready.
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
OTC Safety Rule Delayed to March 21, 2025
The FDA delayed the final rule titled "Nonprescription Drug Product With an Additional Condition for Nonprescription Use" so it will not take effect until March 21, 2025. Drug manufacturers and sellers who would need to follow new safety steps before selling certain over-the-counter medicines do not have to comply or incur related costs until that date, giving them extra time to prepare.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in